Page images
PDF
EPUB
[blocks in formation]
[blocks in formation]

Alphabetical list of witnesses-Continued

Harrop, eslie D., general counsel, American Drug Manufacturers
Association__.

Hoge, James F., general counsel, The Proprietary Association__.

Larrick, George P., Deputy Commissioner, Food and Drug Adminis-

tration, Federal Security Agency-

Leake, James P., M. D., Washington, D. C.

Martin, Walter B., M.D., on behalf of American Medical Association_
Sibley, George H., vice president, E. R. Squibb & Sons___
Volwiler, Dr. Ernest H., president and general manager, Abbott

Laboratories _ _

Warnack, Roy S., retail druggist of Los Angeles, Calif

Wheeler, W. M., Jr., secretary and general counsel, Eli Lilly & Co...

Page

119

235

212

153

237

42

230

Department of the Treasury.

33

Statements, data and communications:

Fred Bartenstein, general attorney, Merck & Co., Inc.: Statement
before Senate Labor and Public Welfare Committee on S. 1186
(Humphrey bill) in behalf of Merck & Co., Inc.

219

148

100

217

[blocks in formation]

Bristol, Henry P., Bristol-Myers Co., New York, N. Y., letter dated Aug.
15, 1951

275

[merged small][ocr errors][merged small]

Doran, Alfred A., director of Professional Relations, Thomas Leeming &

Co., Inc., New York, N. Y., letter dated Aug. 31, 1951____

Durland, J. R., plant manager, Monsanto Chemical Co., telegram dated

Aug. 17, 1951.

Flanagan, James G., counsel, Drug, Chemical and Allied Trades Section,
New York Board of Trade, Inc., New York, N. Y., letter dated Sept. 11,

1951.

282

« PreviousContinue »